search
Back to results

Evaluation of 3D Visualization for Total Colectomy (3Dvs2DforUC)

Primary Purpose

Ulcerative Colitis

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
3-dimensional visualization
2-dimensional visualization
Sponsored by
The Cleveland Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ulcerative Colitis

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Indication for surgery must be Ulcerative Colitis
  • Patient age between 18 and 80
  • Elective procedure
  • BMI between 17 and 30
  • Total colectomy with end ileostomy, without proctectomy

Exclusion Criteria:

  • Any preoperative diagnosis other than UC
  • Patient age< 18, or >80
  • Emergency surgery
  • Previous gastrointestinal surgery
  • BMI>30
  • Pregnancy
  • Presence of any gastrointestinal tract malignancy
  • Segmental colon resections, completion proctectomy, total proctocolectomy, pouch procedures

Sites / Locations

  • Cleveland Clinic

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

3D Visualization

2D Visualization

Arm Description

3-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using 3D Laparoscopic Surgical Video System. This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons.Effect of using 3D Laparoscopic Surgical Video System on operative outcomes will be evaluated.

2-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using conventional Laparoscopic Surgical Video System. This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons and outcomes will be evaluated.

Outcomes

Primary Outcome Measures

Operating Time
total operating time

Secondary Outcome Measures

Major Complication
Number of Participants with Intraoperative Complications

Full Information

First Posted
February 9, 2015
Last Updated
April 14, 2021
Sponsor
The Cleveland Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT02370056
Brief Title
Evaluation of 3D Visualization for Total Colectomy
Acronym
3Dvs2DforUC
Official Title
Comparative Assessment of Three-dimensional vs. Conventional Laparoscopy in a Total Colectomy Model for Ulcerative Colitis
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
March 2015 (undefined)
Primary Completion Date
May 17, 2019 (Actual)
Study Completion Date
May 17, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Cleveland Clinic

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The anticipated advantages of 3D laparoscopic visualization for the surgeon are greater accuracy and speed in manual skills, translating to decreased operative time, reduced learning curve, and superior safety.We aimed to determine the feasibility of the laparoscopic approach using 3D visualization in the surgical treatment of ulcerative colitis
Detailed Description
Three-dimensional (3D) visualization technology for laparoscopy has been proposed, since the early 1990's, as a method to facilitate laparoscopic performance. However, early 3D laparoscopic technology was limited in terms of image quality, so that its use had not been implemented. The latest technical developments ensure high-definition 3D visualization with the same quality that current two-dimensional (2D) systems provide. The anticipated advantages of 3D laparoscopic visualization for the surgeon are greater accuracy and speed in manual skills, translating to decreased operative time, reduced learning curve, and superior safety . It was reported that, 3D laparoscopic visualization offers significant advantages in enhancing laparoscopic performance, even in novice surgeons, comparing to the 2D systems . We hypothesize that 3D visualization may allow surgeons to reduce the overall operating time with a rate of 10% with comparable perioperative and postoperative outcomes. The primary endpoint of this study is to determine the feasibility of the laparoscopic approach using 3D visualization in the surgical treatment of ulcerative colitis. Secondary endpoints are to determine whether 3D visualization confers benefits such as reduced operating time and intra-operative complications with comparable postoperative outcomes. Device Description: The EXERA III Universal Platform will be used in this study, in conjunction with the ENDOEYE FLEX 3D. The ENDOEYE FLEX 3D can also be used in 2D mode, by utilizing a programmed button on the handle of the scope, or by using the 2D/3D button on the 3D Visualization Unit. The articulating tip of the ENDOEYE FLEX allows for the scope to be used in both single-site and multi-port procedures, providing critical views and allowing a bird's eye view so that the scope is out of the way of other instruments (while still capturing the image at the surgical site). All equipment used in this trial has been cleared under 510(k) approval by the FDA, and has been on the market in the US since April 2013. The Olympus HD 3D Laparoscopic Surgical Video System consists of the following components: CV-190 Processor CLV-190 Light Source 3DV-190 3D Visualization Unit LMD-2451MT/3G4 Sony 24" 3D Monitor IMH-20 Image Capture System UHI-4 Insufflator K10021611 Cart OL-0015-08 Tall Rollstand LTF-190-10-3D ENDOEYE FLEX 3D Videoscope 3D glasses (regular and clip-on styles) Study Size:Mean operating time for laparoscopic subtotal colectomy for medically refractory UC was reported longer with a comparison to open surgery in the recently published studies. Therefore the effort to decrease operating time in laparoscopic colectomy has gained importance. We assumed that, in order to be able to determine a 10% reduction in mean operating time, each group should include 27 patients (80% power and 5% significance). Patients who will undergo laparoscopic total abdominal colectomy (TAC) for UC will be included in the study. All subjects will be randomized into two groups: 3D laparoscopy, and 2D laparoscopy. Three staff surgeons (EG, HK, FR) at the department of colorectal surgery, Cleveland Clinic, Ohio will perform the procedures with 2D and 3D laparoscopy. Each surgeon will perform 9 total colectomies with 3D, and 9 total colectomies with the 2D laparoscopy system. In total, 54 patients will be included (27 patients for each group).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ulcerative Colitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
53 (Actual)

8. Arms, Groups, and Interventions

Arm Title
3D Visualization
Arm Type
Experimental
Arm Description
3-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using 3D Laparoscopic Surgical Video System. This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons.Effect of using 3D Laparoscopic Surgical Video System on operative outcomes will be evaluated.
Arm Title
2D Visualization
Arm Type
Active Comparator
Arm Description
2-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using conventional Laparoscopic Surgical Video System. This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons and outcomes will be evaluated.
Intervention Type
Diagnostic Test
Intervention Name(s)
3-dimensional visualization
Intervention Description
Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 3D mode
Intervention Type
Diagnostic Test
Intervention Name(s)
2-dimensional visualization
Intervention Description
Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 2D mode
Primary Outcome Measure Information:
Title
Operating Time
Description
total operating time
Time Frame
180 minutes
Secondary Outcome Measure Information:
Title
Major Complication
Description
Number of Participants with Intraoperative Complications
Time Frame
180 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Indication for surgery must be Ulcerative Colitis Patient age between 18 and 80 Elective procedure BMI between 17 and 30 Total colectomy with end ileostomy, without proctectomy Exclusion Criteria: Any preoperative diagnosis other than UC Patient age< 18, or >80 Emergency surgery Previous gastrointestinal surgery BMI>30 Pregnancy Presence of any gastrointestinal tract malignancy Segmental colon resections, completion proctectomy, total proctocolectomy, pouch procedures
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Emre Gorgun, MD
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluation of 3D Visualization for Total Colectomy

We'll reach out to this number within 24 hrs